Cargando…
Case report of primary CD20 negative diffuse large B-cell lymphoma
Few groups of aggressive non-Hodgkin’s lymphomas (NHL) that are refractory to standard chemotherapy are rarely reported. Primary CD20 negative diffuse large B cell lymphoma (DLBCL) without human immunodeficiency virus infection is an uncommon presentation and this case report is challenging in terms...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8633642/ https://www.ncbi.nlm.nih.gov/pubmed/34858628 http://dx.doi.org/10.1093/omcr/omab114 |
_version_ | 1784607971499573248 |
---|---|
author | Devi, Kanti Ali, Natashi Ahmed, Arsalan |
author_facet | Devi, Kanti Ali, Natashi Ahmed, Arsalan |
author_sort | Devi, Kanti |
collection | PubMed |
description | Few groups of aggressive non-Hodgkin’s lymphomas (NHL) that are refractory to standard chemotherapy are rarely reported. Primary CD20 negative diffuse large B cell lymphoma (DLBCL) without human immunodeficiency virus infection is an uncommon presentation and this case report is challenging in terms of diagnosis and treatment as well. |
format | Online Article Text |
id | pubmed-8633642 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-86336422021-12-01 Case report of primary CD20 negative diffuse large B-cell lymphoma Devi, Kanti Ali, Natashi Ahmed, Arsalan Oxf Med Case Reports Case Report Few groups of aggressive non-Hodgkin’s lymphomas (NHL) that are refractory to standard chemotherapy are rarely reported. Primary CD20 negative diffuse large B cell lymphoma (DLBCL) without human immunodeficiency virus infection is an uncommon presentation and this case report is challenging in terms of diagnosis and treatment as well. Oxford University Press 2021-11-25 /pmc/articles/PMC8633642/ /pubmed/34858628 http://dx.doi.org/10.1093/omcr/omab114 Text en © The Author(s) 2021. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Case Report Devi, Kanti Ali, Natashi Ahmed, Arsalan Case report of primary CD20 negative diffuse large B-cell lymphoma |
title | Case report of primary CD20 negative diffuse large B-cell lymphoma |
title_full | Case report of primary CD20 negative diffuse large B-cell lymphoma |
title_fullStr | Case report of primary CD20 negative diffuse large B-cell lymphoma |
title_full_unstemmed | Case report of primary CD20 negative diffuse large B-cell lymphoma |
title_short | Case report of primary CD20 negative diffuse large B-cell lymphoma |
title_sort | case report of primary cd20 negative diffuse large b-cell lymphoma |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8633642/ https://www.ncbi.nlm.nih.gov/pubmed/34858628 http://dx.doi.org/10.1093/omcr/omab114 |
work_keys_str_mv | AT devikanti casereportofprimarycd20negativediffuselargebcelllymphoma AT alinatashi casereportofprimarycd20negativediffuselargebcelllymphoma AT ahmedarsalan casereportofprimarycd20negativediffuselargebcelllymphoma |